Correction: The Effect of Inhibitory Signals on the Priming of Drug Hapten–Specific T Cells That Express Distinct Vβ Receptors

Gibson, A., L. Faulkner, M. Lichtenfels, M. Ogese, Z. Al-Attar, A. Alfirevic, P. R. Esser, S. F. Martin, M. Pirmohamed, B. K. Park, and D. J. Naisbitt. 2017. The effect of inhibitory signals on the priming of drug hapten–specific T cells that express distinct Vβ receptors. J. Immunol. 199: 1223–1237.

An affiliation for the fifth author was omitted in the article. The corrected author line and affiliations are shown below.

Andrew Gibson,* Lee Faulkner,* Maike Lichtenfels,* Monday Ogese,*^,† Zaid Al-Attar,*^,‡ Ana Alfirevic,* Philipp R. Esser,^§ Stefan F. Martin,^§ Munir Pirmohamed,* B. Kevin Park,* and Dean J. Naisbitt*

*Department of Molecular and Clinical Pharmacology, Medical Research Council Centre for Drug Safety Science, University of Liverpool, Liverpool L69 3GE, United Kingdom; ^†Pathology Sciences, Drug Safety and Metabolism, AstraZeneca Research and Development, Cambridge CB4 0WG, United Kingdom; ^‡Department of Pharmacology, Al-Kindy College of Medicine, University of Baghdad, Al-Nahda District, Baghdad, Iraq; and ^§Allergy Research Group, Department of Dermatology, Medical Center–University of Freiburg, Freiburg im Breisgau, 79104 Freiburg, Germany

• Copyright © 2018 by The American Association of Immunologists, Inc.